SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-05-002642
Filing Date
2005-03-16
Accepted
2005-03-16 16:09:23
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 ATHEROGENICS, INC. g93828e10vk.htm 10-K 496875
2 EX-10.33 EQUITY OWNERSHIP AGREEMENT g93828exv10w33.txt EX-10.33 36123
3 EX-23.01 CONSENT OF ERNST & YOUNG LLP g93828exv23w01.txt EX-23.01 856
4 EX-24.01 POWERS OF ATTORNEY g93828exv24w01.txt EX-24.01 3230
5 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g93828exv31w1.txt EX-31.1 4049
6 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g93828exv31w2.txt EX-31.2 4172
7 EX-32 SECTION 906 CERTIFICATION OF THE CEO AND CFO g93828exv32.txt EX-32 2995
  Complete submission text file 0000950144-05-002642.txt   550575
Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Filer) CIK: 0001107601 (see all company filings)

IRS No.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31261 | Film No.: 05685612
SIC: 2834 Pharmaceutical Preparations